AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Sofosbuvir; Velpatasvir in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MyHep ALL Tablets Tablet | B4-9585 | Healthline Limited | active | 29 Jan 2030 |
| Epclusa Tablets 400/100 mg Tablet | C4-1333 | Phillips Pharmaceuticals (Nigeria) Limited | active | 29 Nov 2025 |
Sofosbuvir; Velpatasvir — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Sofosbuvir; Velpatasvir, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Sofosbuvir; Velpatasvir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.